Neonatology
Original Paper
Neurodevelopmental Outcomes in Preterm Infants with White Matter Injury Using a New MRI ClassificationMartinez-Biarge M.a · Groenendaal F.b · Kersbergen K.J.b · Benders M.J.N.L.b · Foti F.a · van Haastert I.C.b · Cowan F.M.a · de Vries L.S.baDepartment of Paediatrics, Imperial College London, London, United Kingdom
bDepartment of Neonatology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands |
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: October 18, 2018
Accepted: February 26, 2019
Published online: May 20, 2019
Issue release date: October 2019
Number of Print Pages: 9
Number of Figures: 3
Number of Tables: 1
ISSN: 1661-7800 (Print)
eISSN: 1661-7819 (Online)
For additional information: https://www.karger.com/NEO
Abstract
Objective: The aim of this study was to evaluate whether a new MRI scoring system for preterm non-haemorrhagic white matter injury (WMI), derived from the analysis of the natural evolution of WMI throughout the neonatal period until term-equivalent age, can be used for outcome prediction. Methods: Eighty-two infants <36 weeks gestation with WMI diagnosed from sequential cranial ultrasound and confirmed on neonatal MRI were retrospectively included. WMI was classified in four grades of severity. Neurodevelopmental data at a median age of 24 months were analysed. Results: In 74 surviving children WMI severity was strongly associated with the presence and severity of cerebral palsy (CP) and other neurodevelopmental impairments (Spearman’s rank correlation 0.88, p < 0.001). Only 3 children with grade I WMI (9%) developed CP (all ambulant) and their developmental scores were not different to those from the controls, although they started walking significantly later (p = 0.036). Of the 6 children with grade II, 83% developed CP (mild in most), whereas 91% of the 34 children with grade III had CP (moderate-severe in 76%) and all had some degree of neurodevelopmental impairment. Three children with grade III WMI did not develop CP; their imaging showed, in contrast to children who developed CP, that the cysts did not affect the corticospinal tracts; also, myelin in the posterior limb of the internal capsule appeared normal in 2 children and suboptimal in 1. Conclusions: This MRI scoring system for preterm WMI can be used to predict neurodevelopmental outcomes. Individualized assessment of the site of lesions and the progression of myelination improves prognostic accuracy.
© 2019 S. Karger AG, Basel
Related Articles:
References
- van Haastert IC, Groenendaal F, Uiterwaal CS, Termote JU, van der Heide-Jalving M, Eijsermans MJ, et al. Decreasing incidence and severity of cerebral palsy in prematurely born children. J Pediatr. 2011 Jul;159(1):86–91.e1.
- Sellier E, Platt MJ, Andersen GL, Krägeloh-Mann I, De La Cruz J, Cans C; Surveillance of Cerebral Palsy Network. Decreasing prevalence in cerebral palsy: a multi-site European population-based study, 1980 to 2003. Dev Med Child Neurol. 2016 Jan;58(1):85–92.
- De Vries LS, Van Haastert IL, Rademaker KJ, Koopman C, Groenendaal F. Ultrasound abnormalities preceding cerebral palsy in high-risk preterm infants. J Pediatr. 2004 Jun;144(6):815–20.
- Vohr BR, Wright LL, Poole WK, McDonald SA. Neurodevelopmental outcomes of extremely low birth weight infants <32 weeks’ gestation between 1993 and 1998. Pediatrics. 2005 Sep;116(3):635–43.
- Linsell L, Malouf R, Morris J, Kurinczuk JJ, Marlow N. Prognostic factors for cerebral palsy and motor impairment in children born very preterm or very low birthweight: a systematic review. Dev Med Child Neurol. 2016 Jun;58(6):554–69.
-
de Vries LS, Eken P, Dubowitz LMS. The spectrum of leukomalacia using cranial ultrasound. Behav Brain Res. 1992;49:1–6.
External Resources
- Guo T, Duerden EG, Adams E, Chau V, Branson HM, Chakravarty MM, et al. Quantitative assessment of white matter injury in preterm neonates: association with outcomes. Neurology. 2017 Feb;88(7):614–22.
- Miller SP, Cozzio CC, Goldstein RB, Ferriero DM, Partridge JC, Vigneron DB, et al. Comparing the diagnosis of white matter injury in premature newborns with serial MR imaging and transfontanel ultrasonography findings. AJNR Am J Neuroradiol. 2003 Sep;24(8):1661–9.
- Woodward LJ, Anderson PJ, Austin NC, Howard K, Inder TE. Neonatal MRI to predict neurodevelopmental outcomes in preterm infants. N Engl J Med. 2006 Aug;355(7):685–94.
- Kidokoro H, Neil JJ, Inder TE. New MR imaging assessment tool to define brain abnormalities in very preterm infants at term. AJNR Am J Neuroradiol. 2013 Nov-Dec;34(11):2208–14.
- Sarkar S, Shankaran S, Barks J, Do BT, Laptook AR, Das A, et al. Outcome of preterm infants with transient cystic periventricular leukomalacia on serial cranial imaging up to term equivalent age. J Pediatr. 2018 Apr;195:59–65.e3.
- Martinez-Biarge M, Groenendaal F, Kersbergen KJ, Benders MJ, Foti F, Cowan FM, et al. MRI based white matter injury classification: the importance of sequential imaging and time of injury when interpreting the term age MRI. PLoS One. 2016;11:e0156245.
- Palisano RJ, Hanna SE, Rosenbaum PL, Russell DJ, Walter SD, Wood EP, et al. Validation of a model of gross motor function for children with cerebral palsy. Phys Ther. 2000 Oct;80(10):974–85.
- Tusor N, Benders MJ, Counsell SJ, Nongena P, Ederies MA, Falconer S, et al. Punctate White Matter Lesions Associated With Altered Brain Development And Adverse Motor Outcome In Preterm Infants. Sci Rep. 2017 Oct;7(1):13250.
- Arberet C, Proisy M, Fausser JL, Curt M, Bétrémieux P, Tréguier C, et al. Isolated neonatal MRI punctate white matter lesions in very preterm neonates and quality of life at school age. J Neonatal Perinatal Med. 2017;10(3):257–66.
- de Bruïne FT, van den Berg-Huysmans AA, Leijser LM, Rijken M, Steggerda SJ, van der Grond J, et al. Clinical implications of MR imaging findings in the white matter in very preterm infants: a 2-year follow-up study. Radiology. 2011 Dec;261(3):899–906.
- Kersbergen KJ, Benders MJ, Groenendaal F, Koopman-Esseboom C, Nievelstein RA, van Haastert IC, et al. Different patterns of punctate white matter lesions in serially scanned preterm infants. PLoS One. 2014 Oct;9(10):e108904.
- Cornette LG, Tanner SF, Ramenghi LA, Miall LS, Childs AM, Arthur RJ, et al. Magnetic resonance imaging of the infant brain: anatomical characteristics and clinical significance of punctate lesions. Arch Dis Child Fetal Neonatal Ed. 2002 May;86(3):F171–7.
- Pierrat V, Duquennoy C, van Haastert IC, Ernst M, Guilley N, de Vries LS. Ultrasound diagnosis and neurodevelopmental outcome of localised and extensive cystic periventricular leucomalacia. Arch Dis Child Fetal Neonatal Ed. 2001 May;84(3):F151–6.
- Sarkar S, Shankaran S, Laptook AR, Sood BG, Do B, Stoll BJ, et al.; Generic Database Subcommittee of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Screening Cranial Imaging at Multiple Time Points Improves Cystic Periventricular Leukomalacia Detection. Am J Perinatol. 2015 Aug;32(10):973–9.
-
Ment LR, Bada HS, Barnes P, Grant PE, Hirtz D, Papile LA, et al. Practice parameter: neuroimaging of the neonate: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2002;58:1726–38.
-
Pearce R, Baardsnes J. Term MRI for small preterm babies: do parents really want to know and why has nobody asked them? Acta Paediatr. 2012;101(10):1013–5.
- Janvier A, Farlow B, Baardsnes J, Pearce R, Barrington KJ. Measuring and communicating meaningful outcomes in neonatology: A family perspective. Semin Perinatol. 2016 Dec;40(8):571–7.
- Edwards AD, Redshaw ME, Kennea N, Rivero-Arias O, Gonzales-Cinca N, Nongena P, et al.; ePrime Investigators. Effect of MRI on preterm infants and their families: a randomised trial with nested diagnostic and economic evaluation. Arch Dis Child Fetal Neonatal Ed. 2018 Jan;103(1):F15–21.
- Woodward LJ, Clark CA, Bora S, Inder TE. Neonatal white matter abnormalities an important predictor of neurocognitive outcome for very preterm children. PLoS One. 2012;7(12):e51879.
- Cheong JL, Miller SP. Imaging the neonatal brain in the 21st century: why, when and how? Arch Dis Child Fetal Neonatal Ed. 2018 Jan;103(1):F4–5.
- Kersbergen KJ, de Vries LS, Groenendaal F, van Haastert IC, Chew AT, Makropoulos A, et al. Corticospinal Tract Injury Precedes Thalamic Volume Reduction in Preterm Infants with Cystic Periventricular Leukomalacia. J Pediatr. 2015 Aug;167(2):260–8.e3.
- Zubiaurre-Elorza L, Soria-Pastor S, Junqué C, Fernandez-Espejo D, Segarra D, Bargalló N, et al. Thalamic changes in a preterm sample with periventricular leukomalacia: correlation with white-matter integrity and cognitive outcome at school age. Pediatr Res. 2012 Apr;71(4 Pt 1):354–60.
Article / Publication Details
Received: October 18, 2018
Accepted: February 26, 2019
Published online: May 20, 2019
Issue release date: October 2019
Number of Print Pages: 9
Number of Figures: 3
Number of Tables: 1
ISSN: 1661-7800 (Print)
eISSN: 1661-7819 (Online)
For additional information: https://www.karger.com/NEO
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
